Novartis
NVS
#57
Rank
ยฃ190.21 B
Marketcap
ยฃ99.13
Share price
-0.20%
Change (1 day)
28.53%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Earnings for Novartis (NVS)

Earnings in 2025 (TTM): ยฃ12.44 Billion

According to Novartis's latest financial reports the company's current earnings are ยฃ56.37 Billion. In 2024 the company made an earning of ยฃ10.23 Billion, an increase over its 2023 earnings that were of ยฃ6.84 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novartis from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ12.44 B21.68%
2024 ยฃ10.23 B49.51%
2023 ยฃ6.84 B13.48%
2022 ยฃ6.02 B-69.24%
2021 ยฃ19.60 B164.6%
2020 ยฃ7.40 B10.49%
2019 ยฃ6.70 B-36.26%
2018 ยฃ10.52 B55.86%
2017 ยฃ6.74 B15.12%
2016 ยฃ5.86 B-3.9%
2015 ยฃ6.10 B-33.72%
2014 ยฃ9.20 B14.87%
2013 ยฃ8.01 B-2.93%
2012 ยฃ8.25 B2.15%
2011 ยฃ8.08 B-7.94%
2010 ยฃ8.77 B17.94%
2009 ยฃ7.44 B4.45%
2008 ยฃ7.12 B27.5%
2007 ยฃ5.58 B-6.31%
2006 ยฃ5.96 B9.46%
2005 ยฃ5.44 B5.17%
2004 ยฃ5.18 B13.84%
2003 ยฃ4.55 B-38.51%
2002 ยฃ7.40 B574.04%
2001 ยฃ1.09 B83%
2000 ยฃ0.60 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
ยฃ17.31 B 40.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.88 B-27.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.29 B 97.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ6.82 B-44.57%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
ยฃ6.99 B-43.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ1.32 B-89.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bristol-Myers Squibb
BMY
ยฃ6.02 B-51.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ6.10 B-50.44%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ9.81 B-20.28%๐Ÿ‡ฌ๐Ÿ‡ง UK